Acadian Asset Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1
| Closed | – | – | 2186 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1816 |
|
|
2024
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1648 |
|
|
2023
Q4 | – | Sell |
-4,253
| Closed | -$30K | – | 1720 |
|
|
2023
Q3 | $30K | Sell |
4,253
-5,349
| -56% | -$37.7K | ﹤0.01% | 1483 |
|
|
2023
Q2 | $50K | Sell |
9,602
-7,696
| -44% | -$40.1K | ﹤0.01% | 1532 |
|
|
2023
Q1 | $52K | Buy |
+17,298
| New | +$52K | ﹤0.01% | 1510 |
|
|
2022
Q3 | – | Sell |
-776
| Closed | -$10K | – | 1737 |
|
|
2022
Q2 | $10K | Sell |
776
-15,063
| -95% | -$194K | ﹤0.01% | 1642 |
|
|
2022
Q1 | $77K | Sell |
15,839
-15,148
| -49% | -$73.6K | ﹤0.01% | 1412 |
|
|
2021
Q4 | $211K | Buy |
+30,987
| New | +$211K | ﹤0.01% | 1223 |
|
|
2019
Q2 | – | Sell |
-7,861
| Closed | -$478K | – | 1905 |
|
|
2019
Q1 | $478K | Sell |
7,861
-7,010
| -47% | -$426K | ﹤0.01% | 1111 |
|
|
2018
Q4 | $880K | Sell |
14,871
-7,216
| -33% | -$427K | ﹤0.01% | 762 |
|
|
2018
Q3 | $1.79M | Buy |
22,087
+8,082
| +58% | +$654K | 0.01% | 591 |
|
|
2018
Q2 | $1.23M | Buy |
+14,005
| New | +$1.23M | 0.01% | 684 |
|